apo c-ii lipoprotein lipase Apolipoproteins in vascular biology and atherosclerotic disease Apolipoprotein C1: Its Pleiotropic Effects

Accumulating evidence suggests that metabolic disturbances can promote the development of AF through structural and electrophysiological remodelling, but the underlying mechanisms that predispose an individual to AF are aetiology-dependent, thus emphasizing the need for tailored therapeutic strategies to treat AF that target an individuals metabolic profile

The two groups had statistically indistinguishable rates of adverse events (20% vs

Therapeutic potential of novel twin compounds containing tetramethylpyrazine and carnitine substructures in experimental ischemic stroke

Athletes: Between 1,000 and 3,000 mg per day to improve performance and recovery